FDA Inspection
AstraZeneca Dunkerque Production (AZDP)AstraZeneca Dunkerque Production (AZDP) – FDA Inspection, Feb 3, 2022
Record Details
This FDA Inspection record concerns AstraZeneca Dunkerque Production (AZDP), with an inspection on February 3, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 3, 2022
- Product Type
- Drugs
View Company Profile
ID · 64c14df4-1cf0-40cf-8ed3-2d05ef102946
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1275115
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of AstraZeneca Dunkerque Production (AZDP)
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 21, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 20, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 30, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AstraZeneca Dunkerque Production (AZDP)
- FDA Inspection 1101056 - 2018-12-21
- FDA Inspection 961861 - 2015-11-20
- FDA Inspection 839238 - 2013-05-17
- FDA Inspection 560743 - 2009-01-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.